COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.

authors

  • Riad, Abanoub
  • Schunemann, Holger
  • Attia, Sameh
  • Peričić, Tina
  • Žuljević, Marija
  • Jürisson, Mikk
  • Kalda, Ruth
  • Lang, Katrin
  • Morankar, Sudhakar
  • Yesuf, Elias
  • Mekhemar, Mohamed
  • Danso-Appiah, Anthony
  • Sofi-Mahmudi, Ahmad
  • Pérez-Gaxiola, Giordano
  • Dziedzic, Arkadiusz
  • Apóstolo, João
  • Cardoso, Daniela
  • Marc, Janja
  • Moreno-Casbas, Mayte
  • Wiysonge, Charles
  • Qaseem, Amir
  • Gryschek, Anna
  • Tadić, Ivana
  • Hussain, Salman
  • Khan, Mohammed
  • Klugarova, Jitka
  • Pokorna, Andrea
  • Koščík, Michal
  • Klugar, Miloslav

publication date

  • July 25, 2021